What do systematic reviews say?

Leuprorelin vs treosulfan

It is very uncertain whether leuprorelin changes neurotoxicity№ of participants: 73(1 RCT) compared with treosulfan (very low certainty).

• Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer 2016 · Cochrane Headline outcomes only
  RR 0.32 [0.01, 7.71]
  Studies not reported
  Very low